Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study
This study is ongoing, but not recruiting participants.
Children's Hospital of Pittsburgh
Information provided by (Responsible Party):
Silva Arslanian, M.D., Children's Hospital of Pittsburgh
First received: March 18, 2008
Last updated: July 30, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||September 2013|
|Estimated Primary Completion Date:||September 2013 (Final data collection date for primary outcome measure)|
Tfayli H, Ulnach JW, Lee S, Sutton-Tyrrell K, Arslanian S. Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors. J Clin Endocrinol Metab. 2011 May;96(5):1311-9. Epub 2011 Feb 16.